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Routine prenatal first and second trimester serum markers are measured in pregnant 
women for aneuploidy screening. Literature supports an association between abnormal 
markers and adverse pregnancy outcomes relating to placental dysfunction and fetal 
growth disorders. However, there is paucity of information on whether a woman with 
abnormal markers in one pregnancy is at risk for abnormal markers in a subsequent 
pregnancy as well as the risk of adverse pregnancy outcomes in women with low PAPP-A, 
a risk factor for fetal growth restriction, and a normally growing fetus (AGA). We 
present two analyses: (1) the risk of recurrent abnormal serum markers in consecutive 
pregnancies; (2) the risk of adverse outcomes for a woman with low PAPP-A and AGA 
fetus. Patients for both analyses were identified from a database, with data available for 
markers in consecutive pregnancies in (1) and maternal characteristics/delivery for (2). 
We performed a retrospective cohort analysis via chart review and used student’s t-test, 
chi-square, or Fisher’s exact test where appropriate. For each marker analyzed, there 
was an increased risk of having an abnormal marker in a subsequent pregnancy after 
having that marker in the first. In measuring cross-markers, we found no increased risk. 
In comparing low PAPP-A cases with normal PAPP-A controls, we found an increased 
risk of cesarean section for the cases with no trend regarding non-reassuring fetal 
heart rate. Further studies are necessary to investigate potential underlying maternal 
pathophysiology leading to abnormal serum markers and if fetal testing or planned 
delivery for low PAPP-A cases is indicated.
